GLAND PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,728 INR | -0.59% |
|
-2.00% | -10.19% |
| Apr. 08 | Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals | CI |
| Apr. 08 | Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 1,859.60 | 2,140.40 | 2,007.25 |
| Spread/Res. | -7.06% | -19.25% | -13.89% |
| Spread/Supp. | +2.23% | +15.94% | +23.67% |
| Support | 1,690.70 | 1,490.75 | 1,397.55 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GLAND Stock
- Charts Gland Pharma Limited
